info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • All Products

    OUR PRODUCTS

    Allieva Pharma offers a wide range of pharmaceutical products including tablets, capsules, and injections. Our products are manufactured with high-quality standards and trusted across India and international markets.

    DASALIEVA 50MG Dasatinib Tablet IP 50mg by Allieva Pharma Private Limited

    DASALIEVA 50MG

    Dasatinib Tablet IP 50mg

    DASALIEVA 50 mg contains Dasatinib, an oral tyrosine kinase inhibitor (TKI). It inhibits BCR-ABL kinase and SRC family kinases, blocking abnormal signaling pathways responsible for uncontrolled proliferation of leukemic cells. Dasatinib is effective in many cases resistant or intolerant to imatinib.

    View Details
    CRIZLIEVA 250MG Crizotinib Tablets 250mg by Allieva Pharma Private Limited

    CRIZLIEVA 250MG

    Crizotinib Tablets 250mg

    CRIZLIEVA 250 mg contains Crizotinib, an oral tyrosine kinase inhibitor (TKI). It targets ALK (anaplastic lymphoma kinase), ROS1, and MET receptors, inhibiting signaling pathways that drive tumor cell growth and survival. It is especially effective in ALK-positive and ROS1-positive lung cancers.

    View Details
    AFALIEVA 30MG Afatinib Tablets IP 30mg by Allieva Pharma Private Limited

    AFALIEVA 30MG

    Afatinib Tablets IP 30mg

    AFALIEVA 30 mg contains Afatinib, an oral irreversible ErbB family tyrosine kinase inhibitor (TKI). It covalently inhibits EGFR (ErbB1) and HER2 (ErbB2) receptors, blocking downstream signaling pathways involved in tumor cell growth and survival. It is effective in EGFR mutation–positive lung cancers.

    View Details
    AFALIEVA 40MG Afatinib Tablets IP 40mg by Allieva Pharma Private Limited

    AFALIEVA 40MG

    Afatinib Tablets IP 40mg

    AFALIEVA 40 mg contains Afatinib, an oral irreversible ErbB family tyrosine kinase inhibitor (TKI). It blocks EGFR (ErbB1) and HER2 (ErbB2) signaling by covalently binding to the receptor, thereby inhibiting tumor cell growth and survival. Afatinib is effective against tumors with EGFR activating mutations.

    View Details
    IMNOLIEVA 4MG Pomalidomide Capsules 4mg by Allieva Pharma Private Limited

    IMNOLIEVA 4MG

    Pomalidomide Capsules 4mg

    IMNOLIEVA 4 mg contains Pomalidomide, an oral immunomodulatory anticancer drug (IMiD) and a third-generation analogue of thalidomide. It works by modulating immune responses, inhibiting angiogenesis, and inducing apoptosis of malignant plasma cells.

    View Details
    IMNOLIEVA 2MG Pomalidomide Capsules 2mg by Allieva Pharma Private Limited

    IMNOLIEVA 2MG

    Pomalidomide Capsules 2mg

    IMNOLIEVA 2 mg contains Pomalidomide, an oral immunomodulatory anticancer drug (IMiD) and a third-generation analogue of thalidomide. It works by modulating the immune system, inhibiting angiogenesis, and inducing apoptosis of malignant plasma cells.

    View Details
    MEGESLIEVA 160MG Megestrol Tablets IP 160mg by Allieva Pharma Private Limited

    MEGESLIEVA 160MG

    Megestrol Tablets IP 160mg

    MEGESLIEVA 160 mg contains Megestrol Acetate, a synthetic progestational hormone. It has appetite-stimulating and anti-estrogenic properties and is commonly used to manage cancer-related anorexia and as hormonal therapy in certain hormone-responsive cancers.

    View Details
    GEFLIEVA 250MG Gefitinib Tablets IP 250mg by Allieva Pharma Private Limited

    GEFLIEVA 250MG

    Gefitinib Tablets IP 250mg

    GEFLIEVA 250 mg contains Gefitinib, an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It selectively inhibits EGFR signaling, which is involved in tumor cell proliferation and survival. Gefitinib is especially effective in tumors with activating EGFR mutations.

    View Details
    CAPELIEVA 500MG Capecitabine Tablets IP 500mg by Allieva Pharma Private Limited

    CAPELIEVA 500MG

    Capecitabine Tablets IP 500mg

    CAPELIEVA 500 mg contains Capecitabine, an oral fluoropyrimidine chemotherapy agent. It is a prodrug of 5-Fluorouracil (5-FU) that is selectively activated in tumor tissues by thymidine phosphorylase, leading to inhibition of DNA synthesis and tumor cell death.

    View Details
    ABIRALIEVA 500MG Abiraterone Acetate Tablets IP 500mg by Allieva Pharma Private Limited

    ABIRALIEVA 500MG

    Abiraterone Acetate Tablets IP 500mg

    ABIRALIEVA 500 mg contains Abiraterone Acetate, an oral androgen biosynthesis inhibitor. It blocks the enzyme CYP17 (17α-hydroxylase/17,20-lyase), which is essential for androgen production in the testes, adrenal glands, and prostate tumor tissue. This results in profound suppression of circulating and intratumoral androgens, slowing prostate cancer growth.

    View Details
    ABIRALIEVA 250MG Abiraterone Acetate Tablets IP 25mg by Allieva Pharma Private Limited

    ABIRALIEVA 250MG

    Abiraterone Acetate Tablets IP 25mg

    ABIRALIEVA 250 mg contains Abiraterone Acetate, an oral androgen biosynthesis inhibitor. It works by irreversibly inhibiting CYP17 (17α-hydroxylase/17,20-lyase), an enzyme essential for androgen production in the testes, adrenal glands, and prostate tumor tissue. This leads to profound suppression of androgen levels and slows prostate cancer progression.

    View Details
    PALBOLIEVA 125MG Palbociclib Capsules 125mg by Allieva Pharma Private Limited

    PALBOLIEVA 125MG

    Palbociclib Capsules 125mg

    PALBOLIEVA 125 mg contains Palbociclib, an oral cyclin-dependent kinase (CDK) 4/6 inhibitor. It inhibits CDK4 and CDK6, causing cell-cycle arrest in the G1 phase, thereby slowing the growth of hormone receptor–positive breast cancer cells.

    View Details

    24/7 Clients Support

    Best Price

    Quality Assurance